Christopher McMaster

Feb 8, 2024 | nature.com | Gareth Baynam |Christopher McMaster |Etienne Richer |Helen Malherbe |Melissa Haendel |Simon Easteal | +1 more

Achieving a diagnosis for Indigenous people living with a rare, often genetic, disease is crucial for equitable healthcare. The International Rare Disease Research Consortium convened a global Task Force to bridge the gap in diagnosing Indigenous rare diseases, and identify solutions to tackle the health inequity faced by Indigenous people.

Feb 6, 2024 | acrjournals.onlinelibrary.wiley.com | Alix Bird |Christopher McMaster |David Liew |Alix Bird MBBS

Christopher McMaster FRACP, MBBS Department of Rheumatology, Austin Health, Victoria, Melbourne, Australia Department of Clinical Pharmacology and Therapeutic, Austin Health, Victoria, Melbourne, Australia Centre for Digital Transformation of Health and School of Computing and Information Systems, University of Melbourne, Victoria, Melbourne, AustraliaSearch for more papers by this author

Jun 1, 2023 | frontiersin.org | Chi-Shin Wu |Christopher McMaster

1 IntroductionAdverse Drug Reaction (ADR), mainly refers to a harmful reaction unrelated to the purpose of the medication caused by a qualified drug in normal dosage (Edwards and Aronson, 2000). Since the 1950s, the number of new drugs in the world has increased dramatically, and there are tens of thousands of drug varieties. With the increase in the variety of drugs, the probability of adverse drug events has also increased dramatically.

Feb 7, 2023 | medscape.com | Lauren Oakden-Rayner |Christopher McMaster |Luke Smith |Alix Bird

Abstract and Introduction Abstract Rheumatoid arthritis is an autoimmune condition that predominantly affects the synovial joints, causing joint destruction, pain, and disability. Historically, the standard for measuring the long-term efficacy of disease-modifying antirheumatic drugs has been the assessment of plain radiographs with scoring techniques that quantify joint damage.